| Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike J Prévost, R Gasser, G Beaudoin-Bussières, J Richard, R Duerr, ... Cell Reports Medicine 1 (7), 2020 | 237 | 2020 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 206 | 2021 |
| Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, ... MBio 11 (5), 10.1128/mbio. 02590-20, 2020 | 185 | 2020 |
| Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset SP Anand, J Prévost, M Nayrac, G Beaudoin-Bussières, M Benlarbi, ... Cell Reports Medicine 2 (6), 2021 | 181 | 2021 |
| Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles M Lu, PD Uchil, W Li, D Zheng, DS Terry, J Gorman, W Shi, B Zhang, ... Cell host & microbe 28 (6), 880-891. e8, 2020 | 181 | 2020 |
| A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Cell host & microbe 29 (7), 1137-1150. e6, 2021 | 172 | 2021 |
| Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children E Lin, B Kiniboro, L Gray, S Dobbie, L Robinson, A Laumaea, S Schöpflin, ... PloS one 5 (2), e9047, 2010 | 171 | 2010 |
| Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 R Gasser, M Cloutier, J Prévost, C Fink, É Ducas, S Ding, N Dussault, ... Cell reports 34 (9), 2021 | 115 | 2021 |
| Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses A Tauzin, SY Gong, G Beaudoin-Bussières, D Vézina, R Gasser, L Nault, ... Cell host & microbe 30 (1), 97-109. e5, 2022 | 90 | 2022 |
| SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses D Chatterjee, A Tauzin, L Marchitto, SY Gong, M Boutin, C Bourassa, ... Cell reports 38 (9), 2022 | 60 | 2022 |
| A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Biorxiv, 2021.03. 18.435972, 2021 | 46 | 2021 |
| Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality E Brunet-Ratnasingham, SP Anand, P Gantner, A Dyachenko, ... Science Advances 7 (48), eabj5629, 2021 | 45 | 2021 |
| Identification of SARS-CoV-2–specific immune alterations in acutely ill patients RM Rebillard, M Charabati, C Grasmuck, A Filali-Mouhim, O Tastet, ... The Journal of clinical investigation 131 (8), 2021 | 38 | 2021 |
| The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice I Ullah, G Beaudoin-Bussières, K Symmes, M Cloutier, E Ducas, A Tauzin, ... Cell Reports Medicine 4 (1), 2023 | 33 | 2023 |
| Antibody binding to SARS-CoV-2 S glycoprotein correlates with but does not predict neutralization S Ding, A Laumaea, M Benlarbi, G Beaudoin-Bussières, R Gasser, ... Viruses 12 (11), 1214, 2020 | 31 | 2020 |
| Evaluating humoral immunity against SARS-CoV-2: Validation of a plaque-reduction neutralization test and a multilaboratory comparison of conventional and surrogate … EJ Valcourt, K Manguiat, A Robinson, YC Lin, KT Abe, S Mubareka, ... Microbiology Spectrum 9 (3), e00886-21, 2021 | 23 | 2021 |
| Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen M Nayrac, M Dubé, G Sannier, A Nicolas, L Marchitto, O Tastet, A Tauzin, ... Cell Reports 39 (13), 2022 | 20 | 2022 |
| Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors A Laumaea, AB Smith III, J Sodroski, A Finzi Current Opinion in HIV and AIDS 15 (5), 300-308, 2020 | 19 | 2020 |
| A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses A Tauzin, SY Gong, D Chatterjee, S Ding, MM Painter, RR Goel, ... Cell Reports 41 (4), 2022 | 18 | 2022 |
| Antigenicity of the Mu (B. 1.621) and A. 2.5 SARS-CoV-2 spikes D Chatterjee, A Tauzin, A Laumaea, SY Gong, Y Bo, A Guilbault, ... Viruses 14 (1), 144, 2022 | 17 | 2022 |
